Skip to main content
Premium Trial:

Request an Annual Quote

Trinity Biotech Gets CE Mark for Rapid COVID-19 Antigen Test

NEW YORK — Trinity Biotech said on Friday that it has received CE marking for its 10-minute COVID-19 antigen test.

The lateral flow test uses anterior nasal swab samples and provides results within 10 minutes, with 99 percent sensitivity and specificity, according to the Dublin-based company.

Trinity said that it is exploring regulatory approvals for the test in other markets. Earlier this month, it closed a $45 million strategic investment from South Korea-based MiCo.